-
Something wrong with this record ?
Sensitive CE-MS method for monitoring of riociguat and desmethylriociguat levels in human serum
T. Hložek, M. Štícha, M. Bursová, I. Jelínek, P. Tůma, R. Čabala
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
260531/SVV/2020
Charles University project - International
GAUK 11920
Charles University project - International
GAUK - International
SVV - International
- MeSH
- Electrophoresis, Capillary methods MeSH
- Electrolytes MeSH
- Liquid-Liquid Extraction MeSH
- Spectrometry, Mass, Electrospray Ionization methods MeSH
- Humans MeSH
- Limit of Detection MeSH
- Linear Models MeSH
- Pyrazoles blood chemistry isolation & purification pharmacokinetics MeSH
- Pyrimidines blood chemistry isolation & purification pharmacokinetics MeSH
- Reproducibility of Results MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Riociguat is novel antihypertensive drug for treatment of pulmonary hypertension. As such, it is still being tested in many clinical and pharmacokinetic trials. Existing methods that determine serum riociguat and desmethylriociguat (DMR) are based solely on liquid chromatography with mass spectrometry. Therefore, we present a novel capillary electrophoresis with mass spectrometry method (CE-MS) for their determination in human serum as alternative method for ongoing trials. Complete resolution of both analytes was achieved by means of pH optimization of ammonium formate background electrolytes that are fully compatible with ESI/MS detection. Simple liquid-liquid extraction was used as sample pretreatment. The calibration dependence of the method was linear (in the range of 10-1000 ng/mL), with adequate accuracy (90.1-114.9%) and precision (13.4%). LOD and LOQ were arbitrarily set at 10 ng/mL for both analytes. Clinical applicability was validated using serum samples from patients treated with riociguat in pharmacokinetic study and the results corresponded with reference HPLC-MS/MS values. Capillary electrophoresis proved to be sensitive and selective tool for the analysis of riociguat and DMR.
Department of Analytical Chemistry Faculty of Science Charles University Prague Czech Republic
Department of Hygiene 3rd Faculty of Medicine Charles University Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020034
- 003
- CZ-PrNML
- 005
- 20210830101633.0
- 007
- ta
- 008
- 210728s2020 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/elps.202000135 $2 doi
- 035 __
- $a (PubMed)32640044
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Hložek, Tomáš $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Department of Hygiene, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Analytical Chemistry, Faculty of Chemical Technology, University of Pardubice, Pardubice, Czech Republic
- 245 10
- $a Sensitive CE-MS method for monitoring of riociguat and desmethylriociguat levels in human serum / $c T. Hložek, M. Štícha, M. Bursová, I. Jelínek, P. Tůma, R. Čabala
- 520 9_
- $a Riociguat is novel antihypertensive drug for treatment of pulmonary hypertension. As such, it is still being tested in many clinical and pharmacokinetic trials. Existing methods that determine serum riociguat and desmethylriociguat (DMR) are based solely on liquid chromatography with mass spectrometry. Therefore, we present a novel capillary electrophoresis with mass spectrometry method (CE-MS) for their determination in human serum as alternative method for ongoing trials. Complete resolution of both analytes was achieved by means of pH optimization of ammonium formate background electrolytes that are fully compatible with ESI/MS detection. Simple liquid-liquid extraction was used as sample pretreatment. The calibration dependence of the method was linear (in the range of 10-1000 ng/mL), with adequate accuracy (90.1-114.9%) and precision (13.4%). LOD and LOQ were arbitrarily set at 10 ng/mL for both analytes. Clinical applicability was validated using serum samples from patients treated with riociguat in pharmacokinetic study and the results corresponded with reference HPLC-MS/MS values. Capillary electrophoresis proved to be sensitive and selective tool for the analysis of riociguat and DMR.
- 650 _2
- $a elektrolyty $7 D004573
- 650 _2
- $a elektroforéza kapilární $x metody $7 D019075
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a extrakce kapalina-kapalina $7 D059625
- 650 _2
- $a pyrazoly $x krev $x chemie $x izolace a purifikace $x farmakokinetika $7 D011720
- 650 _2
- $a pyrimidiny $x krev $x chemie $x izolace a purifikace $x farmakokinetika $7 D011743
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a hmotnostní spektrometrie s elektrosprejovou ionizací $x metody $7 D021241
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Štícha, Martin $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
- 700 1_
- $a Bursová, Miroslava $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Jelínek, Ivan $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic
- 700 1_
- $a Tůma, Petr $u Department of Hygiene, Third Faculty of Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Čabala, Radomír $u Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic $u Institute of Forensic Medicine and Toxicology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00001508 $t Electrophoresis $x 1522-2683 $g Roč. 41, č. 18-19 (2020), s. 1564-1567
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32640044 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101633 $b ABA008
- 999 __
- $a ok $b bmc $g 1690761 $s 1140480
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 41 $c 18-19 $d 1564-1567 $e 20200731 $i 1522-2683 $m Electrophoresis $n Electrophoresis $x MED00001508
- GRA __
- $a 260531/SVV/2020 $p Charles University project $2 International
- GRA __
- $a GAUK 11920 $p Charles University project $2 International
- GRA __
- $p GAUK $2 International
- GRA __
- $p SVV $2 International
- LZP __
- $a Pubmed-20210728
